Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis

被引:163
作者
Busino, L [1 ]
Chiesa, M [1 ]
Draetta, GF [1 ]
Donzelli, M [1 ]
机构
[1] European Inst Oncol, I-20141 Milan, Italy
关键词
Cdc25A; APC/C; SCF; checkpoints;
D O I
10.1038/sj.onc.1207394
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In eukaryotic cells, control mechanisms of cell-cycle progression have evolved to accurately monitor the integrity of genetic information to be transferred to the progeny. Cdc25A phosphatase is an essential activator of cell-cycle progression and is targeted by checkpoint signals. Ubiquitylation regulates Cdc25A activity through. ne tuning of its protein levels. Two different ubiquitin ligases (APC/C and SCF complex) are involved in Cdc25A turnover. While APC/C is involved in regulating Cdc25A at the exit of mitosis, SCF regulates the abundance of Cdc25A in S phase and G2. In response to DNA damage or to stalled replication, the activation of the ATM and ATR protein kinases leads to Chk1 and Chk2 activation and to Cdc25A hyperphosphorylation. These events stimulate SCF-mediated ubiquitylation of Cdc25A and its proteolysis. This contributes to delaying cell-cycle progression, thereby preventing genomic instability. Based on recent findings, we discuss the role of Cdc25A ubiquitylation and degradation in cell-cycle progression and in response to DNA damage. Moreover, we discuss the role of phosphorylation at multiple sites in triggering ubiquitylation signals.
引用
收藏
页码:2050 / 2056
页数:7
相关论文
共 71 条
  • [1] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [2] Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001
  • [3] Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation
    Bernardi, R
    Liebermann, DA
    Hoffman, B
    [J]. ONCOGENE, 2000, 19 (20) : 2447 - 2454
  • [4] Blomberg I, 1999, MOL CELL BIOL, V19, P6183
  • [5] Broggini M, 2000, ANTICANCER RES, V20, P4835
  • [6] Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
    Busino, L
    Donzelli, M
    Chiesa, M
    Guardavaccaro, D
    Ganoth, D
    Dorrello, NV
    Hershko, A
    Pagano, M
    Draetta, GF
    [J]. NATURE, 2003, 426 (6962) : 87 - 91
  • [7] Role of the Cdc25A phosphatase in human breast cancer
    Cangi, MG
    Cukor, B
    Soung, P
    Signoretti, S
    Moreira, G
    Ranashinge, M
    Cady, B
    Pagano, M
    Loda, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (06) : 753 - 761
  • [8] SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
    Carrano, AC
    Eytan, E
    Hershko, A
    Pagano, M
    [J]. NATURE CELL BIOLOGY, 1999, 1 (04) : 193 - 199
  • [9] Identification of a family of human F-box proteins
    Cenciarelli, C
    Chiaur, DS
    Guardavaccaro, D
    Parks, W
    Vidal, M
    Pagano, M
    [J]. CURRENT BIOLOGY, 1999, 9 (20) : 1177 - 1179
  • [10] Oncogenic potential of a C.elegans cdc25 gene is demonstrated by a gain-of-function allele
    Clucas, C
    Cabello, J
    Büssing, I
    Schnabel, R
    Johnstone, IL
    [J]. EMBO JOURNAL, 2002, 21 (04) : 665 - 674